Promoting and regulating generic medicines: Brazil in comparative perspective
ABSTRACT Promoting the use of generic drugs can constitute a core instrument for countries’ national pharmaceutical policies, one that reduces drug expenditure while expanding health care access. Despite the potential importance of such policy measures and the differences among national practices, s...
Main Authors: | , |
---|---|
Format: | Article in Journal/Newspaper |
Language: | English Spanish Portuguese |
Published: |
Pan American Health Organization
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/30124c8011254af0922acc614ce032dd |
id |
ftdoajarticles:oai:doaj.org/article:30124c8011254af0922acc614ce032dd |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:30124c8011254af0922acc614ce032dd 2023-05-15T15:03:03+02:00 Promoting and regulating generic medicines: Brazil in comparative perspective Elize Massard da Fonseca Kenneth C. Shadlen 2017-04-01T00:00:00Z https://doaj.org/article/30124c8011254af0922acc614ce032dd EN ES PT eng spa por Pan American Health Organization http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892017000100501&lng=en&tlng=en https://doaj.org/toc/1680-5348 1680-5348 https://doaj.org/article/30124c8011254af0922acc614ce032dd Revista Panamericana de Salud Pública, Vol 41, Iss 0 (2017) Drugs generic therapeutic equivalency generic drug policy Brazil Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 article 2017 ftdoajarticles 2022-12-31T02:42:33Z ABSTRACT Promoting the use of generic drugs can constitute a core instrument for countries’ national pharmaceutical policies, one that reduces drug expenditure while expanding health care access. Despite the potential importance of such policy measures and the differences among national practices, scholars embarking on comparative analysis lack a roadmap for determining which dimensions of generic drug policy to assess and compare. This report fills that gap by considering national rules and regulations across four dimensions deemed crucial to any evaluation: demonstrated therapeutic equivalence; pharmaceutical packaging and labeling; drug prescription; and drug substitution. Furthermore, this report examines how the diverse interests of public and private sector stakeholders might shape generic drug policy and its implementation. To illustrate the challenges and conflicts behind policy development and implementation, this report focuses on the case of Brazil. Article in Journal/Newspaper Arctic Directory of Open Access Journals: DOAJ Articles Arctic |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English Spanish Portuguese |
topic |
Drugs generic therapeutic equivalency generic drug policy Brazil Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Drugs generic therapeutic equivalency generic drug policy Brazil Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Elize Massard da Fonseca Kenneth C. Shadlen Promoting and regulating generic medicines: Brazil in comparative perspective |
topic_facet |
Drugs generic therapeutic equivalency generic drug policy Brazil Medicine R Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
description |
ABSTRACT Promoting the use of generic drugs can constitute a core instrument for countries’ national pharmaceutical policies, one that reduces drug expenditure while expanding health care access. Despite the potential importance of such policy measures and the differences among national practices, scholars embarking on comparative analysis lack a roadmap for determining which dimensions of generic drug policy to assess and compare. This report fills that gap by considering national rules and regulations across four dimensions deemed crucial to any evaluation: demonstrated therapeutic equivalence; pharmaceutical packaging and labeling; drug prescription; and drug substitution. Furthermore, this report examines how the diverse interests of public and private sector stakeholders might shape generic drug policy and its implementation. To illustrate the challenges and conflicts behind policy development and implementation, this report focuses on the case of Brazil. |
format |
Article in Journal/Newspaper |
author |
Elize Massard da Fonseca Kenneth C. Shadlen |
author_facet |
Elize Massard da Fonseca Kenneth C. Shadlen |
author_sort |
Elize Massard da Fonseca |
title |
Promoting and regulating generic medicines: Brazil in comparative perspective |
title_short |
Promoting and regulating generic medicines: Brazil in comparative perspective |
title_full |
Promoting and regulating generic medicines: Brazil in comparative perspective |
title_fullStr |
Promoting and regulating generic medicines: Brazil in comparative perspective |
title_full_unstemmed |
Promoting and regulating generic medicines: Brazil in comparative perspective |
title_sort |
promoting and regulating generic medicines: brazil in comparative perspective |
publisher |
Pan American Health Organization |
publishDate |
2017 |
url |
https://doaj.org/article/30124c8011254af0922acc614ce032dd |
geographic |
Arctic |
geographic_facet |
Arctic |
genre |
Arctic |
genre_facet |
Arctic |
op_source |
Revista Panamericana de Salud Pública, Vol 41, Iss 0 (2017) |
op_relation |
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892017000100501&lng=en&tlng=en https://doaj.org/toc/1680-5348 1680-5348 https://doaj.org/article/30124c8011254af0922acc614ce032dd |
_version_ |
1766334959480471552 |